Source: Clinical and Experimental Allergy. Unidades: ICB, FMRP, FCFRP
Assunto: IMUNOLOGIA
ABNT
FONSECA, Denise Morais da et al. Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clinical and Experimental Allergy, v. 42, n. 1, p. 131-143, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2222.2011.03845.x. Acesso em: 31 ago. 2024.APA
Fonseca, D. M. da, Wowk, P. F., Paula, M. O., Campos, L. W., Gembre, A. F., Turato, W. M., et al. (2012). Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clinical and Experimental Allergy, 42( 1), 131-143. doi:10.1111/j.1365-2222.2011.03845.xNLM
Fonseca DM da, Wowk PF, Paula MO, Campos LW, Gembre AF, Turato WM, Ramos SG, Dias-Baruffi M, Barboza R, Gomes E, Silva CL, Russo M, Bonato VLD. Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway [Internet]. Clinical and Experimental Allergy. 2012 ; 42( 1): 131-143.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/j.1365-2222.2011.03845.xVancouver
Fonseca DM da, Wowk PF, Paula MO, Campos LW, Gembre AF, Turato WM, Ramos SG, Dias-Baruffi M, Barboza R, Gomes E, Silva CL, Russo M, Bonato VLD. Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway [Internet]. Clinical and Experimental Allergy. 2012 ; 42( 1): 131-143.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/j.1365-2222.2011.03845.x